The University of Chicago Header Logo

Connection

Michael Becker to Amifostine

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Amifostine.
Michael Becker
Connection Strength
0.091
Amifostine
  1. A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection. Biol Blood Marrow Transplant. 2011 Jul; 17(7):1033-42.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.